IL264458B - Cannabis composition - Google Patents

Cannabis composition

Info

Publication number
IL264458B
IL264458B IL264458A IL26445819A IL264458B IL 264458 B IL264458 B IL 264458B IL 264458 A IL264458 A IL 264458A IL 26445819 A IL26445819 A IL 26445819A IL 264458 B IL264458 B IL 264458B
Authority
IL
Israel
Prior art keywords
cannabis compounds
cannabis
compounds
Prior art date
Application number
IL264458A
Other languages
English (en)
Hebrew (he)
Other versions
IL264458A (en
Inventor
Harry Karelis
Mara Gordon
Stewart Smith
Stewart Washer
Original Assignee
Zelda Therapeutics Operations Pty Ltd
Harry Karelis
Mara Gordon
Stewart Smith
Stewart Washer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65524553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL264458(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2017901222A external-priority patent/AU2017901222A0/en
Application filed by Zelda Therapeutics Operations Pty Ltd, Harry Karelis, Mara Gordon, Stewart Smith, Stewart Washer filed Critical Zelda Therapeutics Operations Pty Ltd
Publication of IL264458A publication Critical patent/IL264458A/en
Publication of IL264458B publication Critical patent/IL264458B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL264458A 2016-08-03 2019-01-24 Cannabis composition IL264458B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662370299P 2016-08-03 2016-08-03
AU2017901222A AU2017901222A0 (en) 2017-04-04 Cannabis composition
AU2017902065A AU2017902065A0 (en) 2017-05-31 Cannabis composition
PCT/AU2017/050817 WO2018023166A1 (en) 2016-08-03 2017-08-03 Cannabis composition

Publications (2)

Publication Number Publication Date
IL264458A IL264458A (en) 2019-02-28
IL264458B true IL264458B (en) 2021-06-30

Family

ID=65524553

Family Applications (1)

Application Number Title Priority Date Filing Date
IL264458A IL264458B (en) 2016-08-03 2019-01-24 Cannabis composition

Country Status (15)

Country Link
US (2) US11304925B1 (cg-RX-API-DMAC7.html)
EP (1) EP3493800A4 (cg-RX-API-DMAC7.html)
JP (2) JP2019526541A (cg-RX-API-DMAC7.html)
KR (3) KR102447510B1 (cg-RX-API-DMAC7.html)
CN (1) CN109789123A (cg-RX-API-DMAC7.html)
AU (4) AU2017305103B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019001794A2 (cg-RX-API-DMAC7.html)
CA (1) CA3031300A1 (cg-RX-API-DMAC7.html)
CL (1) CL2019000266A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019001043A2 (cg-RX-API-DMAC7.html)
IL (1) IL264458B (cg-RX-API-DMAC7.html)
MX (1) MX386086B (cg-RX-API-DMAC7.html)
PE (2) PE20230607A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201900501RA (cg-RX-API-DMAC7.html)
WO (1) WO2018023166A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210013645A (ko) 2016-08-03 2021-02-04 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
CN110944632A (zh) 2017-06-19 2020-03-31 塞尔达治疗手术有限公司 睡眠障碍组合物及其治疗
CA3103178A1 (en) * 2017-06-27 2019-01-03 Enviro BioMedical Laboratories Inc. Blended cannabis compounds and methods of making the same
US20200276155A1 (en) * 2017-09-15 2020-09-03 Zelda Therapeutics Operations Pty Ltd Composition and method for treating autism
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
WO2019199861A2 (en) * 2018-04-09 2019-10-17 Ellevet Sciences Hemp extract for treatment of pain in animals
WO2019227167A1 (en) * 2018-06-01 2019-12-05 The University Of Sydney Compositions and treatments
EP3807385A1 (en) * 2018-06-14 2021-04-21 Biosoma B.V. Process for the extraction of oil-soluble components from plant material
US11040932B2 (en) 2018-10-10 2021-06-22 Treehouse Biotech, Inc. Synthesis of cannabigerol
WO2020084423A1 (en) * 2018-10-24 2020-04-30 Radient Technologies Innovations Inc. Extraction-based contract execution
WO2020121312A1 (en) * 2018-12-12 2020-06-18 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl)
NL2022615B1 (en) * 2019-02-21 2020-08-31 Patrick Alexander Unger Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight
CN113784704A (zh) * 2019-04-17 2021-12-10 诺狄更斯公司 快速崩解大麻素片剂
EP4041000A1 (en) * 2019-10-09 2022-08-17 Nicoventures Trading Limited Aerosolisable material
US12011471B2 (en) * 2019-12-19 2024-06-18 Atlas365 Incorporated Extracts enriched with polyphenolic compounds and related methods
CN115605289A (zh) * 2020-04-29 2023-01-13 利加尔有限合伙公司（Nz） 印迹聚合物及其使用方法
MX2022015799A (es) * 2020-06-12 2023-04-11 Zelira Therapeutics Operations Pty Ltd Composicion y metodo para el tratamiento del dolor cronico.
KR20220126653A (ko) * 2021-03-08 2022-09-16 주식회사 엘지생활건강 칸나비게롤을 포함하는 조성물
IL307444A (en) * 2021-04-05 2023-12-01 The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo Preparations and methods for the treatment of cancer
US12440454B2 (en) 2022-02-01 2025-10-14 Portland Technology Holdings Llc Pharmaceutical compositions containing hemp extract for administration to felines and related methods
WO2025231524A1 (en) * 2024-05-08 2025-11-13 Heyday RX Pty Ltd Cannabinoid compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10051427C1 (de) * 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
GB2418612A (en) 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids
KR20070118069A (ko) 2004-12-09 2007-12-13 인시스 테라퓨틱스, 인코포레이티드 실온에서 안정한 드로나비놀 제형
WO2007032962A2 (en) 2005-09-09 2007-03-22 University Of Kentucky Compositions and methods for intranasal delivery of tricyclic cannabinoids
US8980940B2 (en) * 2006-11-10 2015-03-17 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
GB201117956D0 (en) 2011-10-18 2011-11-30 Otsuka Pharma Co Ltd Phytocannabinoids for use in the treatment of breast cancer
CN104619318A (zh) * 2012-05-03 2015-05-13 回音制药公司 含有δ9-四氢大麻酚的大麻植物分离物及其制备方法
US10792318B2 (en) 2013-03-14 2020-10-06 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
WO2014145490A2 (en) 2013-03-15 2014-09-18 Biotech Institute, Llc Breeding, production, processing and use of specialty cannabis
HRP20191097T1 (hr) 2013-10-29 2019-09-20 Biotech Institute, Llc Uzgoj, proizvodnja, obrada i upotreba specijalnog kanabisa
US9044390B1 (en) 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
WO2015200049A1 (en) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
US11793769B2 (en) * 2014-08-25 2023-10-24 Jai Shankar Sukul Device with compositions for delivery to the lungs, the oral mucosa and the brain
BR112017008301B1 (pt) * 2014-10-21 2021-12-07 United Cannabis Corp Extratos de cannabis e métodos de sua preparação e uso
AU2015360349B2 (en) * 2014-12-12 2020-10-08 Ojai Energetics Pbc Microencapsulated cannabinoid compositions
WO2016105514A1 (en) * 2014-12-23 2016-06-30 Biotech Institute, Llc A reliable and robust method for the analysis of cannabinoids and terpenes in cannabis
EP3250200A4 (en) 2015-01-31 2018-09-19 Constance Therapeutics, Inc. Methods for preparation of cannabis oil extracts and compositions
KR20210013645A (ko) 2016-08-03 2021-02-04 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
EP3493799A4 (en) 2016-08-03 2020-04-01 Zelda Therapeutics Operations Pty Ltd CANNABIS

Also Published As

Publication number Publication date
KR20220132674A (ko) 2022-09-30
AU2021205115B2 (en) 2023-06-15
KR20190034576A (ko) 2019-04-02
JP2021054836A (ja) 2021-04-08
AU2018100920B4 (en) 2019-02-07
KR20210129747A (ko) 2021-10-28
AU2019203529A1 (en) 2019-06-06
EP3493800A4 (en) 2020-04-08
US11304925B1 (en) 2022-04-19
PE20230607A1 (es) 2023-04-13
AU2017305103B2 (en) 2019-02-21
NZ750272A (en) 2021-09-24
AU2017305103A1 (en) 2018-07-05
EP3493800A1 (en) 2019-06-12
US20220202767A1 (en) 2022-06-30
BR112019001794A2 (pt) 2019-05-07
CL2019000266A1 (es) 2019-10-04
JP2019526541A (ja) 2019-09-19
AU2019203529B2 (en) 2021-04-29
CA3031300A1 (en) 2018-02-08
AU2018100920A4 (en) 2018-08-02
IL264458A (en) 2019-02-28
MX2019001286A (es) 2019-06-13
WO2018023166A1 (en) 2018-02-08
KR102447510B1 (ko) 2022-09-27
SG11201900501RA (en) 2019-02-27
MX386086B (es) 2025-03-18
JP7139559B2 (ja) 2022-09-21
CO2019001043A2 (es) 2020-06-19
CN109789123A (zh) 2019-05-21
PE20200677A1 (es) 2020-06-11
AU2021205115A1 (en) 2021-08-12

Similar Documents

Publication Publication Date Title
IL264458B (en) Cannabis composition
IL264461A (en) Cannabis composition
DK3405050T3 (da) Børnesikret snusbeholder
PT3298027T (pt) Compostos depsipéptidos antelmínticos
EP3609871A4 (en) ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS
DK3436823T3 (da) Antigen-array
DK3335532T3 (da) Tandharve
DK3402792T3 (da) Quinolin-2-on-derivater
DK4039675T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
SMT202200173T1 (it) Composti
DK3445708T3 (da) Stigbøjle
EP3402021A4 (en) GRAB WIRE
DK3509963T3 (da) Pallecontainer
DK3452590T3 (da) Plademagnet
LT3362444T (lt) Junginiai
DK3575238T3 (da) Pallecontainer
DK3597189T3 (da) Krystallinske forbindelser
DK3528829T3 (da) Bacitracin-alginat-oligomer-konjugater
EP3399976C0 (en) BENZOTHIAZOLE AMPHOPHILES
DE112017000734A5 (de) Glycolsensor
DK3672941T3 (da) Pyridylpyridonforbindelser
DE112017006386A5 (de) Schraubarbeitszylinder
DK3323708T3 (da) Bovfender
LT3331885T (lt) Junginiai
DK3672962T3 (da) Morpholinylpyridonforbindelser

Legal Events

Date Code Title Description
FF Patent granted